ICU Medical, Inc. (ICUI)
USD 154.07
(-1.97%)
USD 154.07
(-1.97%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.25 Billion USD | -0.93% |
| 2022 | 2.27 Billion USD | 73.21% |
| 2021 | 1.31 Billion USD | 3.56% |
| 2020 | 1.27 Billion USD | 0.38% |
| 2019 | 1.26 Billion USD | -9.56% |
| 2018 | 1.4 Billion USD | 8.31% |
| 2017 | 1.29 Billion USD | 240.72% |
| 2016 | 379.37 Million USD | 11.04% |
| 2015 | 341.66 Million USD | 10.48% |
| 2014 | 309.26 Million USD | -1.42% |
| 2013 | 313.71 Million USD | -1.0% |
| 2012 | 316.86 Million USD | 4.86% |
| 2011 | 302.19 Million USD | 6.19% |
| 2010 | 284.58 Million USD | 22.92% |
| 2009 | 231.51 Million USD | 13.08% |
| 2008 | 204.72 Million USD | 8.82% |
| 2007 | 188.13 Million USD | -6.68% |
| 2006 | 201.61 Million USD | 27.98% |
| 2005 | 157.53 Million USD | 108.51% |
| 2004 | 75.55 Million USD | -29.63% |
| 2003 | 107.35 Million USD | 22.26% |
| 2002 | 87.8 Million USD | 27.16% |
| 2001 | 69.05 Million USD | 22.89% |
| 2000 | 56.19 Million USD | 19.56% |
| 1999 | 47 Million USD | 18.09% |
| 1998 | 39.8 Million USD | 30.92% |
| 1997 | 30.4 Million USD | 23.58% |
| 1996 | 24.6 Million USD | 15.49% |
| 1995 | 21.3 Million USD | 29.09% |
| 1994 | 16.5 Million USD | 44.74% |
| 1993 | 11.4 Million USD | 11.76% |
| 1992 | 10.2 Million USD | 36.0% |
| 1991 | 7.5 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 595.82 Million USD | 5.39% |
| 2024 Q1 | 565.95 Million USD | -3.75% |
| 2023 FY | 2.25 Billion USD | -0.93% |
| 2023 Q1 | 568.64 Million USD | -1.62% |
| 2023 Q4 | 587.98 Million USD | 6.27% |
| 2023 Q3 | 553.31 Million USD | 0.73% |
| 2023 Q2 | 549.31 Million USD | -3.4% |
| 2022 Q2 | 561 Million USD | 3.29% |
| 2022 FY | 2.27 Billion USD | 73.21% |
| 2022 Q4 | 578.01 Million USD | -3.32% |
| 2022 Q3 | 597.85 Million USD | 6.57% |
| 2022 Q1 | 543.12 Million USD | 59.5% |
| 2021 Q2 | 321.67 Million USD | 1.14% |
| 2021 Q3 | 336.06 Million USD | 4.47% |
| 2021 FY | 1.31 Billion USD | 3.56% |
| 2021 Q4 | 340.52 Million USD | 1.33% |
| 2021 Q1 | 318.04 Million USD | -0.75% |
| 2020 FY | 1.27 Billion USD | 0.38% |
| 2020 Q1 | 328.6 Million USD | 4.15% |
| 2020 Q2 | 303.37 Million USD | -7.68% |
| 2020 Q3 | 318.56 Million USD | 5.01% |
| 2020 Q4 | 320.45 Million USD | 0.59% |
| 2019 Q3 | 307.47 Million USD | -1.54% |
| 2019 Q4 | 315.52 Million USD | 2.62% |
| 2019 Q2 | 312.28 Million USD | -5.64% |
| 2019 FY | 1.26 Billion USD | -9.56% |
| 2019 Q1 | 330.93 Million USD | -2.78% |
| 2018 Q4 | 340.37 Million USD | 4.04% |
| 2018 Q1 | 372.03 Million USD | 0.52% |
| 2018 Q2 | 360.46 Million USD | -3.11% |
| 2018 Q3 | 327.16 Million USD | -9.24% |
| 2018 FY | 1.4 Billion USD | 8.31% |
| 2017 Q1 | 247.73 Million USD | 158.9% |
| 2017 Q4 | 370.12 Million USD | 7.83% |
| 2017 Q3 | 343.23 Million USD | 3.54% |
| 2017 Q2 | 331.51 Million USD | 33.82% |
| 2017 FY | 1.29 Billion USD | 240.72% |
| 2016 Q2 | 96.72 Million USD | 7.64% |
| 2016 FY | 379.37 Million USD | 11.04% |
| 2016 Q4 | 95.68 Million USD | -1.46% |
| 2016 Q3 | 97.1 Million USD | 0.4% |
| 2016 Q1 | 89.85 Million USD | -0.59% |
| 2015 FY | 341.66 Million USD | 10.48% |
| 2015 Q4 | 90.38 Million USD | 5.08% |
| 2015 Q1 | 81.48 Million USD | 1.99% |
| 2015 Q3 | 86.01 Million USD | 2.67% |
| 2015 Q2 | 83.78 Million USD | 2.82% |
| 2014 Q3 | 77.45 Million USD | -1.55% |
| 2014 FY | 309.26 Million USD | -1.42% |
| 2014 Q1 | 73.23 Million USD | -6.04% |
| 2014 Q2 | 78.67 Million USD | 7.44% |
| 2014 Q4 | 79.89 Million USD | 3.15% |
| 2013 Q4 | 77.94 Million USD | -5.89% |
| 2013 Q3 | 82.81 Million USD | 5.28% |
| 2013 Q2 | 78.66 Million USD | 5.87% |
| 2013 Q1 | 74.29 Million USD | -10.13% |
| 2013 FY | 313.71 Million USD | -1.0% |
| 2012 FY | 316.86 Million USD | 4.86% |
| 2012 Q2 | 77.28 Million USD | 2.34% |
| 2012 Q3 | 81.4 Million USD | 5.34% |
| 2012 Q4 | 82.67 Million USD | 1.56% |
| 2012 Q1 | 75.51 Million USD | -1.25% |
| 2011 Q2 | 77.79 Million USD | 8.85% |
| 2011 FY | 302.19 Million USD | 6.19% |
| 2011 Q4 | 76.47 Million USD | 0.02% |
| 2011 Q3 | 76.45 Million USD | -1.72% |
| 2011 Q1 | 71.47 Million USD | -5.49% |
| 2010 Q1 | 64.36 Million USD | -7.81% |
| 2010 Q4 | 75.62 Million USD | -0.15% |
| 2010 FY | 284.58 Million USD | 22.92% |
| 2010 Q3 | 75.73 Million USD | 9.98% |
| 2010 Q2 | 68.86 Million USD | 6.99% |
| 2009 Q4 | 69.81 Million USD | 29.37% |
| 2009 FY | 231.51 Million USD | 13.08% |
| 2009 Q1 | 54.33 Million USD | -4.25% |
| 2009 Q2 | 53.39 Million USD | -1.72% |
| 2009 Q3 | 53.96 Million USD | 1.06% |
| 2008 FY | 204.72 Million USD | 8.82% |
| 2008 Q4 | 56.74 Million USD | 3.67% |
| 2008 Q2 | 48.59 Million USD | 8.82% |
| 2008 Q1 | 44.65 Million USD | -1.96% |
| 2008 Q3 | 54.73 Million USD | 12.64% |
| 2007 Q2 | 48.89 Million USD | 0.12% |
| 2007 FY | 188.13 Million USD | -6.68% |
| 2007 Q1 | 48.83 Million USD | -7.53% |
| 2007 Q4 | 45.54 Million USD | 1.51% |
| 2007 Q3 | 44.86 Million USD | -8.23% |
| 2006 Q1 | 48.78 Million USD | 12.84% |
| 2006 Q3 | 48.6 Million USD | -5.49% |
| 2006 Q4 | 52.8 Million USD | 8.66% |
| 2006 FY | 201.61 Million USD | 27.98% |
| 2006 Q2 | 51.42 Million USD | 5.42% |
| 2005 Q2 | 40.69 Million USD | 50.24% |
| 2005 FY | 157.53 Million USD | 108.51% |
| 2005 Q4 | 43.23 Million USD | -7.08% |
| 2005 Q1 | 27.08 Million USD | 78.38% |
| 2005 Q3 | 46.52 Million USD | 14.33% |
| 2004 Q2 | 21.66 Million USD | -2.56% |
| 2004 Q3 | 16.46 Million USD | -23.98% |
| 2004 Q1 | 22.23 Million USD | -25.32% |
| 2004 FY | 75.55 Million USD | -29.63% |
| 2004 Q4 | 15.18 Million USD | -7.8% |
| 2003 Q1 | 30.77 Million USD | 27.55% |
| 2003 FY | 107.35 Million USD | 22.26% |
| 2003 Q4 | 29.77 Million USD | 16.64% |
| 2003 Q2 | 21.28 Million USD | -30.85% |
| 2003 Q3 | 25.52 Million USD | 19.93% |
| 2002 Q2 | 22.66 Million USD | 8.43% |
| 2002 FY | 87.8 Million USD | 27.16% |
| 2002 Q4 | 24.12 Million USD | 20.01% |
| 2002 Q3 | 20.1 Million USD | -11.31% |
| 2002 Q1 | 20.9 Million USD | 0.11% |
| 2001 Q3 | 16.21 Million USD | -4.35% |
| 2001 Q2 | 16.95 Million USD | 12.97% |
| 2001 Q4 | 20.88 Million USD | 28.8% |
| 2001 Q1 | 15 Million USD | -9.72% |
| 2001 FY | 69.05 Million USD | 22.89% |
| 2000 Q2 | 13.62 Million USD | -4.39% |
| 2000 Q4 | 16.62 Million USD | 42.08% |
| 2000 FY | 56.19 Million USD | 19.56% |
| 2000 Q1 | 14.24 Million USD | 8.77% |
| 2000 Q3 | 11.69 Million USD | -14.13% |
| 1999 Q4 | 13.1 Million USD | 22.43% |
| 1999 Q2 | 11.7 Million USD | 2.63% |
| 1999 FY | 47 Million USD | 18.09% |
| 1999 Q3 | 10.7 Million USD | -8.55% |
| 1999 Q1 | 11.4 Million USD | 16.33% |
| 1998 Q3 | 9.6 Million USD | -7.69% |
| 1998 Q1 | 10 Million USD | 14.94% |
| 1998 FY | 39.8 Million USD | 30.92% |
| 1998 Q4 | 9.8 Million USD | 2.08% |
| 1998 Q2 | 10.4 Million USD | 4.0% |
| 1997 Q3 | 7.7 Million USD | 6.94% |
| 1997 Q2 | 7.2 Million USD | 5.88% |
| 1997 Q1 | 6.8 Million USD | 4.62% |
| 1997 FY | 30.4 Million USD | 23.58% |
| 1997 Q4 | 8.7 Million USD | 12.99% |
| 1996 Q2 | 6.1 Million USD | 1.67% |
| 1996 FY | 24.6 Million USD | 15.49% |
| 1996 Q3 | 6 Million USD | -1.64% |
| 1996 Q4 | 6.5 Million USD | 8.33% |
| 1996 Q1 | 6 Million USD | 13.21% |
| 1995 Q3 | 4.6 Million USD | -23.33% |
| 1995 Q4 | 5.3 Million USD | 15.22% |
| 1995 Q2 | 6 Million USD | 11.11% |
| 1995 FY | 21.3 Million USD | 29.09% |
| 1995 Q1 | 5.4 Million USD | 8.0% |
| 1994 FY | 16.5 Million USD | 44.74% |
| 1994 Q1 | 4.2 Million USD | 13.51% |
| 1994 Q2 | 3.8 Million USD | -9.52% |
| 1994 Q3 | 3.5 Million USD | -7.89% |
| 1994 Q4 | 5 Million USD | 42.86% |
| 1993 FY | 11.4 Million USD | 11.76% |
| 1993 Q4 | 3.7 Million USD | 48.0% |
| 1993 Q3 | 2.5 Million USD | 8.7% |
| 1993 Q2 | 2.3 Million USD | -20.69% |
| 1993 Q1 | 2.9 Million USD | 3.57% |
| 1992 Q1 | 2.5 Million USD | 38.89% |
| 1992 Q2 | 2.4 Million USD | -4.0% |
| 1992 Q3 | 2.6 Million USD | 8.33% |
| 1992 Q4 | 2.8 Million USD | 7.69% |
| 1992 FY | 10.2 Million USD | 36.0% |
| 1991 Q1 | 1.9 Million USD | 0.0% |
| 1991 FY | 7.5 Million USD | 0.0% |
| 1991 Q2 | 1.9 Million USD | 0.0% |
| 1991 Q3 | 1.9 Million USD | 0.0% |
| 1991 Q4 | 1.8 Million USD | -5.26% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 96.63 Million USD | -2237.841% |
| AngioDynamics, Inc. | 303.91 Million USD | -643.344% |
| AtriCure, Inc. | 399.24 Million USD | -465.85% |
| Avinger, Inc. | 7.65 Million USD | -29423.34% |
| Azenta, Inc. | 665.07 Million USD | -239.681% |
| BioLife Solutions, Inc. | 143.27 Million USD | -1476.82% |
| The Cooper Companies, Inc. | 3.59 Billion USD | 37.128% |
| Daxor Corporation | 1.28 Million USD | -176323.236% |
| Ekso Bionics Holdings, Inc. | 18.27 Million USD | -12259.133% |
| Femasys Inc. | 1.07 Million USD | -210645.263% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 112.25 Million USD | -1912.584% |
| Hologic, Inc. | 4.03 Billion USD | 43.946% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | 68.289% |
| KORU Medical Systems, Inc. | 28.51 Million USD | -7821.847% |
| LeMaitre Vascular, Inc. | 193.48 Million USD | -1067.604% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -195923.181% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -195923.181% |
| Masimo Corporation | 2.04 Billion USD | -10.304% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 97.09 Million USD | -2226.623% |
| Merit Medical Systems, Inc. | 1.25 Billion USD | -79.671% |
| Nephros, Inc. | 14.23 Million USD | -15766.877% |
| NovoCure Limited | 509.33 Million USD | -343.542% |
| NEXGEL, Inc. | 4.08 Million USD | -55148.863% |
| NEXGEL, Inc. | 4.08 Million USD | -55148.863% |
| Singular Genomics Systems, Inc. | 2.91 Million USD | -77506.527% |
| OraSure Technologies, Inc. | 405.47 Million USD | -457.16% |
| Pro-Dex, Inc. | 53.84 Million USD | -4095.688% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 1.78 Million USD | -126810.56% |
| Precision Optics Corporation, Inc. | 19.1 Million USD | -11725.192% |
| QuidelOrtho Corporation | 2.99 Billion USD | 24.641% |
| Repligen Corporation | 638.76 Million USD | -253.671% |
| Sanara MedTech Inc. | 64.98 Million USD | -3376.122% |
| STAAR Surgical Company | 322.41 Million USD | -600.689% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 50.22 Million USD | -4398.101% |
| DENTSPLY SIRONA Inc. | 3.96 Billion USD | 43.023% |
| Jin Medical International Ltd. | 19.82 Million USD | -11297.376% |